SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-007622
Filing Date
2019-05-01
Accepted
2019-05-01 18:25:37
Documents
1
Period of Report
2019-04-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3950
  Complete submission text file 0001213900-19-007622.txt   5637
Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Issuer) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O CALDERA PHARMACEUTICALS, INC ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address
Cunningham, Richard Anthony (Reporting) CIK: 0001624783 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54748 | Film No.: 19789095